neostigmine has been researched along with Alloxan Diabetes in 8 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Intrathecal neostigmine produces a profound analgesic effect in a rat model of diabetic neuropathic pain." | 7.71 | Antiallodynic effect of intrathecal neostigmine is mediated by spinal nitric oxide in a rat model of diabetic neuropathic pain. ( Chen, SR; Khan, GM; Pan, HL, 2001) |
| "Intrathecal neostigmine produces a profound analgesic effect in a rat model of diabetic neuropathic pain." | 3.71 | Antiallodynic effect of intrathecal neostigmine is mediated by spinal nitric oxide in a rat model of diabetic neuropathic pain. ( Chen, SR; Khan, GM; Pan, HL, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mustafa, S | 1 |
| Ismael, HN | 1 |
| Cellini, J | 2 |
| DiNovo, K | 1 |
| Harlow, J | 1 |
| LePard, KJ | 2 |
| Zaura Jukic, AM | 1 |
| KOSAK, R | 1 |
| Chen, SR | 1 |
| Khan, GM | 1 |
| Pan, HL | 1 |
| Iguchi, A | 2 |
| Miura, H | 2 |
| Kunoh, Y | 1 |
| Mizuno, S | 1 |
| Uemura, K | 2 |
| Ishiguro, T | 1 |
| Tamagawa, T | 2 |
| Goshima, K | 1 |
| Sakamoto, N | 2 |
| Yatomi, A | 1 |
| Danysz, A | 1 |
| Wiśniewski, K | 1 |
| Moniuszko, J | 1 |
| Zarebski, M | 1 |
| Buczko, W | 1 |
8 other studies available for neostigmine and Alloxan Diabetes
| Article | Year |
|---|---|
Reactivity of diabetic urinary bladder to the cholinesterase inhibitor neostigmine.
Topics: Animals; Cholinesterase Inhibitors; Diabetes Mellitus, Experimental; Disease Models, Animal; Electri | 2014 |
Regional differences in neostigmine-induced contraction and relaxation of stomach from diabetic guinea pig.
Topics: Animals; Autonomic Nervous System Diseases; Diabetes Mellitus, Experimental; Diabetic Neuropathies; | 2011 |
Neostigmine-induced contraction and nitric oxide-induced relaxation of isolated ileum from STZ diabetic guinea pigs.
Topics: Animals; Diabetes Mellitus, Experimental; Endothelium-Dependent Relaxing Factors; Gastrointestinal M | 2011 |
[The effect of prostigmine on choline content in normal and alloxan-diabetic rat].
Topics: Alloxan; Animals; Choline; Diabetes Mellitus, Experimental; Neostigmine; Rats | 1954 |
Antiallodynic effect of intrathecal neostigmine is mediated by spinal nitric oxide in a rat model of diabetic neuropathic pain.
Topics: Analgesics; Animals; Cholinesterase Inhibitors; Diabetes Mellitus, Experimental; Diabetic Neuropathi | 2001 |
Reciprocal changes of plasma glucose and ketone bodies in fasted and acutely diabetic rats after CNS stimulation.
Topics: Animals; Blood Glucose; Brain; Diabetes Mellitus, Experimental; Epinephrine; Fasting; Fatty Acids, N | 1991 |
CNS stimulation does not affect hepatic venous glucose concentration in severely diabetic rats.
Topics: Animals; Blood Glucose; Cerebral Ventricles; Diabetes Mellitus, Experimental; Epinephrine; Glucagon; | 1991 |
[Effect of certain drugs in alloxan diabetes].
Topics: Animals; Chlorpromazine; Diabetes Mellitus, Experimental; Epinephrine; Mice; Neostigmine; Sodium Sal | 1968 |